Lonergan M, Dey A, Becker K G, Drew P D, Ozato K
Howard Hughes Research Scholars Program, Howard Hughes Medical Institute, National Institute of Neurological Diseases and Stroke, Bethesda, Maryland 20892.
Mol Cell Biol. 1993 Nov;13(11):6629-39. doi: 10.1128/mcb.13.11.6629-6639.1993.
Expression of the beta 2-microglobulin (beta 2-m) and major histocompatibility complex (MHC) class I genes is coordinately regulated. By ligation-mediated polymerase chain reaction, we have analyzed in vivo factor binding to the promoter region of the murine beta 2-m gene. In adult spleen, in which beta 2-m is expressed, strong protection was found in three elements. Two of these elements, the beta 2-m NF-kappa B binding site and the interferon consensus sequence, are homologous to the regulatory elements of the MHC class I genes and were also found to be protected in spleen. A third protected element, PAM, identified in this work, is unique to the beta 2-m gene. None of the elements showed protection in brain tissue, in which neither the beta 2-m nor the MHC class I gene is expressed. In vivo footprinting was also performed with F9 embryonal carcinoma cells, in which expression of the beta 2-m and MHC class I genes is induced at a low level only upon stimulation with retinoic acid (RA). No in vivo protection was detected before and after RA treatment of F9 cells, indicating that RA induction of beta 2-m (and MHC class I) expression occurs without detectable in vivo factor occupancy, whereas EL4 T lymphocytes expressing beta 2-m at a high level exhibited strong protection similar to that in spleen. Despite the lack of in vivo occupancy, the nuclear factors specific for each of the three elements were present in brain tissue and F9 cells as well as in spleen tissue and EL4 cells. We show that PAM, an element identified by its in vivo protection, binds nuclear factors ranging from 40 to 50 kDa in size and is capable of enhancing transcription of a reporter in F9 and other cells. Taken together, these results indicate that in vivo factor occupancy for the beta 2-m and MHC class I promoters is coordinated and occurs through a mechanism other than mere expression of relevant factors.
β2-微球蛋白(β2-m)和主要组织相容性复合体(MHC)I类基因的表达受到协同调控。通过连接介导的聚合酶链反应,我们分析了体内因子与小鼠β2-m基因启动子区域的结合情况。在表达β2-m的成年脾脏中,在三个元件中发现了强烈的保护作用。其中两个元件,即β2-m NF-κB结合位点和干扰素共有序列,与MHC I类基因的调控元件同源,在脾脏中也被发现受到保护。在这项工作中鉴定出的第三个受保护元件PAM,是β2-m基因所特有的。在脑组织中,β2-m和MHC I类基因均不表达,这些元件均未显示出保护作用。我们还用F9胚胎癌细胞进行了体内足迹分析,在F9胚胎癌细胞中,仅在视黄酸(RA)刺激后,β2-m和MHC I类基因才会低水平诱导表达。在F9细胞进行RA处理前后均未检测到体内保护作用,这表明RA诱导β2-m(和MHC I类)表达时,体内因子占据情况无法检测到,而高水平表达β2-m的EL4 T淋巴细胞表现出与脾脏中相似的强烈保护作用。尽管缺乏体内占据情况,但三种元件各自特异的核因子在脑组织、F9细胞以及脾脏组织和EL4细胞中均存在。我们发现,通过其体内保护作用鉴定出的元件PAM,可结合大小在40至50 kDa之间的核因子,并能够增强F9细胞和其他细胞中报告基因的转录。综上所述,这些结果表明,β2-m和MHC I类启动子的体内因子占据是协同的,并且是通过一种不同于相关因子单纯表达的机制发生的。